Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2024 08:00 ET | Source: Biostem Technologies

BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024

BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
January 30, 2024 16:05 ET | Source: Biostem Technologies

Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies

Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
January 11, 2024 08:30 ET | Source: Biostem Technologies

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
December 19, 2023 08:30 ET | Source: Biostem Technologies

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 14, 2023 08:30 ET | Source: Biostem Technologies

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
December 13, 2023 08:30 ET | Source: Biostem Technologies

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
November 13, 2023 17:17 ET | Source: Biostem Technologies

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
November 08, 2023 08:30 ET | Source: Biostem Technologies

BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

POMPANO BEACH, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
November 03, 2023 08:30 ET | Source: Biostem Technologies

BioStem Technologies Closes Oversubscribed $2M Private Placement

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
September 06, 2023 12:00 ET | Source: BioStem Technologies, Inc.

BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell

PENSACOLA, FL, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Lovell® Government Services (‘Lovell’) and BioStem Technologies (POMPANO BEACH, FL, ‘BioStem’) announced today that they have successfully listed...